# S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma

> **NCT02913066** · PHASE2 · UNKNOWN · sponsor: **Mianyang Central Hospital** · enrollment: 88 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **OTHER:** S-1 concurrent radiotherapy
- **OTHER:** S-1 plus Cisplatin concurrent radiotherapy

## Key facts

- **NCT ID:** NCT02913066
- **Lead sponsor:** Mianyang Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2019-03
- **Final completion:** 2019-03
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02913066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02913066, "S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02913066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*